0001209191-19-061050.txt : 20191217
0001209191-19-061050.hdr.sgml : 20191217
20191217200214
ACCESSION NUMBER: 0001209191-19-061050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191213
FILED AS OF DATE: 20191217
DATE AS OF CHANGE: 20191217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cumbo Alexander
CENTRAL INDEX KEY: 0001685994
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 191291088
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-13
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001685994
Cumbo Alexander
215 FIRST STREET
SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2019-12-13
4
M
0
2727
13.71
A
13888
D
Common Stock
2019-12-13
4
M
0
3895
13.71
A
17783
D
Common Stock
2019-12-13
4
M
0
26084
26.24
A
43867
D
Common Stock
2019-12-13
4
S
0
32706
125.50
D
11161
D
Common Stock
2019-12-13
4
S
0
9294
125.50
D
1867
D
Common Stock
3441
I
By grantor retained annuity trust
Stock option (right to buy)
13.71
2019-12-13
4
M
0
2727
0.00
D
2016-09-09
2026-02-28
Common Stock
2727
1123
D
Stock option (right to buy)
13.71
2019-12-13
4
M
0
3895
0.00
D
2017-02-28
2026-02-28
Common Stock
3895
0
D
Stock option (right to buy)
26.24
2019-12-13
4
M
0
26084
0.00
D
2014-01-02
2023-01-02
Common Stock
26084
20881
D
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
/s/ David Tyronne Howton, as Attorney-in-Fact for Alexander Cumbo
2019-12-17